Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rang in Aktien #425
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Aktienkurs
$116.80
Marktkapitalisierung
$51.47B
Veränderung (1 Tag)
0.75%
Veränderung (1 Jahr)
-27.59%
Land
US
Handel Zoetis Inc. (ZTS)

Kategorie

Gewinn für Zoetis Inc. (ZTS)
Gewinn im Dec 2025 TTM: $3.36B
Laut den aktuellen Finanzberichten von Zoetis Inc. betragen die aktuellen Gewinne des Unternehmens $3.36B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $3.13B, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $2.94B betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Zoetis Inc. von 2009 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $3.36B 0.00%
2025 $3.36B 7.25%
2024 $3.13B 6.71%
2023 $2.94B 10.54%
2022 $2.66B 6.75%
2021 $2.49B 24.65%
2020 $2.00B 10.83%
2019 $1.80B 6.57%
2018 $1.69B 10.82%
2017 $1.53B 24.19%
2016 $1.23B 125.32%
2015 $545.00M -33.54%
2014 $820.00M 18.84%
2013 $690.00M -2.82%
2012 $710.00M 80.20%
2011 $394.00M 121.35%
2010 $178.00M -220.27%
2009 $-148.00M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$3.88B 15.51%
DE
$677.05M -79.85%
FR
$1.32B -60.58%
JP
$-11.94M -100.36%
IL
$4.84B 43.96%
GB